BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3471313)

  • 1. Cytogenetic analysis of four human ovarian carcinoma cell lines.
    Sheer D; Sheppard DM; Gorman PA; Ward B; Whelan RD; Hill BT
    Cancer Genet Cytogenet; 1987 Jun; 26(2):339-49. PubMed ID: 3471313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic findings in cell lines derived from four ovarian carcinomas.
    Smith A; Roberts C; van Haaften-Day C; den Dulk G; Russell P; Tattersall MH
    Cancer Genet Cytogenet; 1987 Feb; 24(2):231-42. PubMed ID: 3466675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic studies of four human lung adenocarcinoma cell lines.
    Fan YS; Li P
    Cancer Genet Cytogenet; 1987 Jun; 26(2):317-25. PubMed ID: 3471311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome aberrations in metastatic ovarian cancer: relationship with abnormalities in primary tumors.
    Bello MJ; Rey JA
    Int J Cancer; 1990 Jan; 45(1):50-4. PubMed ID: 2298505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal chromosomes including small metacentrics in 14 ovarian cancers.
    Atkin NB; Baker MC
    Cancer Genet Cytogenet; 1987 Jun; 26(2):355-61. PubMed ID: 3032405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic observations on two ovarian carcinomas with double minutes, one with a 6q- marker chromosome.
    Bullerdiek J; Bartnitzke S; Kahrs E; Schloot W
    Cytobios; 1985; 42(165):15-24. PubMed ID: 3858061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics of a cell line derived from an ovarian papillary serous cystadenocarcinoma.
    Hill SM; Rodgers CS; Hultén MA; Wilson AP
    Cancer Genet Cytogenet; 1984 Aug; 12(4):321-7. PubMed ID: 6744227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Band 1p36 abnormalities and t(1;17) in ovarian carcinoma.
    Thompson FH; Taetle R; Trent JM; Liu Y; Massey-Brown K; Scott KM; Weinstein RS; Emerson JC; Alberts DS; Nelson MA
    Cancer Genet Cytogenet; 1997 Jul; 96(2):106-10. PubMed ID: 9216715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Instability of chromosomes 1, 3, 16, and 17 in primary breast carcinomas inferred by fluorescence in situ hybridization.
    Anamthawat-Jónsson K; Eyfjörd JE; Ogmundsdóttir HM; Pétursdóttir I; Steinarsdóttir M
    Cancer Genet Cytogenet; 1996 May; 88(1):1-7. PubMed ID: 8630972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral ovarian carcinoma: cytogenetic evidence of unicentric origin.
    Pejovic T; Heim S; Mandahl N; Elmfors B; Furgyik S; Flodérus UM; Helm G; Willén H; Mitelman F
    Int J Cancer; 1991 Feb; 47(3):358-61. PubMed ID: 1993543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of 9p in metastatic ovarian adenocarcinomas.
    Bello MJ; Moreno S; Rey JA
    Cancer Genet Cytogenet; 1990 Apr; 45(2):223-9. PubMed ID: 2317770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-related chromosomal changes in chemoresistant human ovarian carcinoma cells.
    Teyssier JR; Bénard J; Ferre D; Da Silva J; Renaud L
    Cancer Genet Cytogenet; 1989 May; 39(1):35-43. PubMed ID: 2731146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-band polymorphisms in lymphocytes of patients with ovarian or breast adenocarcinoma.
    Kivi S; Mikelsaar AV
    Cancer Genet Cytogenet; 1987 Sep; 28(1):77-85. PubMed ID: 3475166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinoma.
    Garewal HS; Sampliner R; Liu Y; Trent JM
    Cancer Genet Cytogenet; 1989 Oct; 42(2):281-6. PubMed ID: 2790761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytogenetic studies of lung cancer].
    Fang Y
    Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):249-52. PubMed ID: 3248479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality.
    Panani AD; Roussos C
    Cancer Lett; 2006 Apr; 235(1):130-5. PubMed ID: 15927360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutional balanced translocations in patients with solid tumors.
    Richard F; Muleris M; Couturier J; Gerbault-Seureau M; Lombard M; Dutrillaux B
    Cancer Genet Cytogenet; 1992 Jul; 61(1):50-2. PubMed ID: 1638480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation (3;8;8)(p22 or p23;p23;q12) in a case of pleomorphic adenoma: similarity to a primary cytogenetic abnormality detected in an endometrial adenocarcinoma.
    Bullerdiek J; Raabe G; Böschen C; Bartnitzke S
    Cancer Genet Cytogenet; 1987 Jul; 27(1):177-80. PubMed ID: 3034396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization analysis using cosmid probes to define chromosome 6q abnormalities in ovarian carcinoma cell lines.
    Lastowska MA; Lillington DM; Shelling AN; Cooke I; Gibbons B; Young BD; Ganesan TS
    Cancer Genet Cytogenet; 1994 Oct; 77(2):99-105. PubMed ID: 7954328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.